The EUROPA trial

Lancet. 2003 Dec 6;362(9399):1935-6; author reply 1936-7. doi: 10.1016/S0140-6736(03)14972-0.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Antihypertensive Agents / adverse effects
  • Calcium Channel Blockers / adverse effects
  • Coronary Disease / drug therapy*
  • Heart Diseases / prevention & control
  • Humans
  • Perindopril / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Perindopril